Is ANVS or AQST more undervalued in 2026?

CirclFi compares Annovis Bio, Inc. (ANVS) and Aquestive Therapeutics, Inc. (AQST) using 13 institutional-grade valuation models. ANVS has a Quality of Company score of 3.9/10 while AQST scores 5.7/10.

Which is a better buy — ANVS or AQST?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ANVS and AQST valuations compare?

ANVS at $1.92 and AQST at $4.02 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ANVS vs AQST Valuation Comparison 2026 — Intrinsic Value Analysis

ANVS

Pharmaceutical Preparations

Annovis Bio, Inc.

Quality

3.9

out of 10

Value Trap

SAFE

Price

$1.92

Last close

Models

7/13

Active

AQST

Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

Quality

5.7

out of 10

Value Trap

LOW

Price

$4.02

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	ANVS Fair Value	ANVS Upside	AQST Fair Value	AQST Upside
Bayesian DCF	Intrinsic	$0.73	-61.8%	$1.38	-65.6%
Earnings Power Value	Intrinsic	—	—	$1.22	-70.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.93	-51.6%	$0.06	-98.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ANVS vs AQST — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ANVS vs AQST — Which Stock Is More Undervalued?

AQST scores higher with a 5.7/10 quality rating vs ANVS's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Annovis Bio, Inc. (ANVS) and Aquestive Therapeutics, Inc. (AQST) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ANVS currently trades at $1.92 with a QOC of 3.9/10, while AQST trades at $4.02 with a QOC of 5.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).